Warfrin is a key element in therapy for atrial fibrillation, deep venous thrombosis (DVT), stroke (cerebrovascular accident and cardiac valve replacement . The authors searced 16,017 active clinical charts for active patients of record for the years 2009-2010. The authors found that 1.96 percent of total Marquette University Dental Clinic patients had a history of warfrin use. INR values for a significant number of dental patients are not within the therapeutic range for their medical conditions. The patients physcian was contacted for warfrin dose regulation prior to invasive dental procedures.